Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biocompatibles' BiodivYsio SV

This article was originally published in The Gray Sheet

Executive Summary

Small vessel coronary stent delivery system receives CE mark for European marketing March 23. An "enhanced force transmission shaft" and "ultra-low" crossing profile allow for treating hard-to-reach lesions, the firm claims. The BiodivYsio SV system is available in stent lengths of 7 mm, 10 mm, 15 mm, and 18 mm, and diameters of 2.0 mm, 2.25 mm and 2.5 mm. The device is approved for use with 5 Fr guided catheters

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014667

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel